2215 YUKON STREET, VANCOUVER, A1
Market cap: $963.9M (2/08/2026)
Price: $3.22
Investor Presentation
Reach Global Settlement of Patent Litigation
AbCellera Biologics Dismisses KPMG as Independent Auditor
Reports Q3 2025 Business Results
Reports Q2 2025 Business Results & First Participants Dosed in a Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms
Shareholder votes
Q3
Q2
Q1
FY 2023
S-3ASR
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Submission Upload
Post-Effective Amendment to Registration Statement
Correspondence